No phaseNot yet recruiting
The PharmFIT Study
Expanding Access to Colorectal Cancer Screening Through Community Pharmacies: The PharmFIT Study
- Sponsor
- UNC Lineberger Comprehensive Cancer Center (Academic or other)
- Enrollment
- 1,500 planned
- Conditions
- Colorectal Cancer
- Interventions
- PharmFIT
- Ages
- adults, older adults
- Registry
- NCT06656936
Full record on ClinicalTrials.gov
From the registry
This study will conduct a randomized controlled trial to assess the impact of a pharmacy-based FIT intervention, Pharmacy-based FIT (PharmFIT), on colorectal cancer screening (CRC) screening rates in primary care patients who are not up to date on CRC screening. Through collaboration with community partners in North Carolina and the Pacific Northwest region, 1) the impact will be evaluated, 2) the implementation will be assessed, and 3) the costs of the PharmFIT intervention cost will be estimated. Patients (n=1,200) will be individually randomized to a usual care arm or a PharmFIT arm and we will determine whether there are statistically significant differences in CRC screening rates. Concurrently, a mixed methods approach will be used to assess a range of preliminary implementation outcomes, identify outcome barriers and facilitators, and identify implementation strategies to support future research. Also, the cost of PharmFIT will be calculated, using collaborative process flow diagramming (PFD) to inform micro-costing and budget impact analysis. Supported by preliminary work…
Primary outcomes
- Service Penetration (Effectiveness)
- Appropriateness of the PharmFIT intervention
- Acceptability of the PharmFIT intervention
- Feasibility of the PharmFIT intervention
History
Study completion expected
Primary completion expected
Started
Last registry update
Registered